Simulations Plus Securities Fraud Investigation
Analysis based on 24 articles · First reported Aug 11, 2025 · Last updated Oct 10, 2025
The market is negatively impacted by the alleged securities fraud by Simulations Plus, leading to significant stock price declines. Investors in Simulations Plus face potential losses and are being encouraged by Bleichmar Fonti & Auld LLP to pursue legal options.
Simulations Plus, a software company in the pharmaceutical, biotechnology, and chemical industries, is under investigation by Bleichmar Fonti & Auld LLP for potential securities fraud. The investigation stems from alleged misrepresentations regarding the successful integration of its June 2024 acquisition, Pro-ficiency Holdings, Inc., and the effectiveness of its internal controls over financial reporting. After hiring Grant Thornton Bharat as its new auditor, Simulations Plus announced disappointing preliminary 3Q 2025 financial results, causing its stock to fall over 24%. Subsequently, the company reported a $77.2 million impairment charge related to prior acquisitions and dismissed Grant Thornton Bharat. The auditor, however, disagreed with Simulations Plus's characterizations, stating that matters related to segment reporting, reporting unit determinations, and internal controls were not resolved to their satisfaction. This news led to another nearly 26% drop in Simulations Plus's stock price, prompting the securities fraud investigation.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard